Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- University of Washington
- Yale University
- Umeå University
- Stanford University
- University of Minnesota
- University of North Carolina at Chapel Hill
- Cornell University
- Nencki Institute of Experimental Biology
- St Jude Children's Research Hospital
- University of Maryland, Baltimore
- Baylor College of Medicine
- Heidelberg University
- Karolinska Institutet (KI)
- King's College London
- Northeastern University
- Rutgers University
- The University of Arizona
- University of California, Los Angeles
- CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences
- Delft University of Technology (TU Delft)
- FAPESP - São Paulo Research Foundation
- Fondazione per l'Istituto oncologico di ricerca IOR
- German Cancer Research Center in the Helmholtz Association (DKFZ)
- Harvard University
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- INSERM
- Josep Carreras Leukaemia Research Institute (IJC)
- KU LEUVEN
- Lunds universitet
- Medizinische Universitaet Wien
- Michigan State University
- New York University
- Oak Ridge National Laboratory
- Research Center for Molecular Medicine (CeMM), ÖAW
- The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences
- The University of North Carolina at Chapel Hill
- The University of Texas at Dallas
- UNIVERSITY OF HELSINKI
- UNIVERSITY OF VIENNA
- University College Dublin
- University Medical Center Utrecht (UMC Utrecht)
- University of Colorado
- University of Copenhagen
- University of Illinois Chicago
- University of Michigan - Ann Arbor
- University of Texas at Dallas
- Université de Reims Champagne Ardenne
- VIB
- Washington University in St. Louis
- Yale University - Department of Genetics
- 40 more »
- « less
-
Field
-
already in place: Existing genome-wide CRISPR screening data from RLT and EBRT models, with compelling hits already identified and a clear path towards clinical translation Isogenic radio-resistant and
-
-erythrocytic and transmission stages of the parasite lifecycle. Current projects include CRISPR/Cas9-based parasite engineering, functional characterization of parasite genes involved in liver infection and
-
-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything
-
level, experience in isolating and working with primary immune cells, experience in precise genetic engineering, for example using CRISPR/Cas9. Further information The position is a full-time fixed-term
-
disease (IBD), and/or experimental autoimmune encephalomyelitis (EAE). Using unbiased genome-wide CRISPR/Cas9 guide RNA library screens and whole kinome analyses, we have identified promising novel
-
CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences | Austria | 2 months ago
CRISPR screening (Bock 2022 Nature Reviews ), and CAR T cell engineering (... Where to apply Website https://www.eurosciencejobs.com/job_display/293955/CeMM_International_Postdoc_P… Requirements Additional
-
thromboinflammation, using cutting-edge approaches such as confocal intravital microscopy, CRISPR-based gene editing, proteomics, and mouse models of human disease. Job Description Primary Duties & Responsibilities
-
pharmacology to map neuroimmune circuits from the molecule to the whole organism. We also have an increasing interest in human immunology and neuroscience and are building the resources (iPSC cells, CRISPR
-
Postdoctoral Associate | Mitochondrial Genomics | Lake Lab — Yale University, Department of Genetics
our research please see our website: https://www.thelakelab.org/ Responsibilities Generate and characterize novel cellular models of mitochondrial genome dysfunction using genome-editing and related
-
and lignocellulosic biomass into domestic fuels and chemicals. Research activities may include creating transformation methods, constructing gene‑expression “genetic parts,” and developing CRISPR‑Cas